Latest News from: ISPOR—The Professional Society for Health Economics and Outcomes Research

Add to Favorites Subscribe Share
Go to Advanced Search

Showing results

110 of 191
VIH_June_cover.jpg

Article ID: 696280

A Framework for the Use of Wearable Medical Devices in Regulatory Clinical Trials

ISPOR—The Professional Society for Health Economics and Outcomes Research

Value in Health, the official journal of ISPOR (the professional society for health economics and outcomes research), announced today the publication of new guidance regarding the selection and evaluation of wearable devices for use in regulatory trials and to support labeling claims.

Released:
19-Jun-2018 8:30 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
VIH_June_cover.jpg

Article ID: 696277

Novel Approach to Assessing US Outpatient Drug Costs for Use in Cost-Effectiveness Analyses

ISPOR—The Professional Society for Health Economics and Outcomes Research

Value in Health, the official journal of ISPOR (the professional society for health economics and outcomes research), announced today the publication of a study introducing a novel strategy for obtaining reasonable drug cost estimates for US-based cost-effectiveness analyses.

Released:
19-Jun-2018 8:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
ISPORsBoardofDirectors2018-2019.jpg

Article ID: 695448

ISPOR Announces 2018-2019 Board of Directors

ISPOR—The Professional Society for Health Economics and Outcomes Research

ISPOR, the professional society for health economics and outcomes research, announced the election of the Society’s 2018-2019 Board of Directors.

Released:
5-Jun-2018 8:35 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
264_ISPOR_KyleKlein_KKP_4567.jpg

Article ID: 695445

ISPOR 2018 Drew Nearly 4000 Stakeholders in Health Economics and Outcomes Research

ISPOR—The Professional Society for Health Economics and Outcomes Research

ISPOR, the professional society for health economics and outcomes research, recently concluded its ISPOR 2018 conference in Baltimore, MD, USA. The conference drew 3741 healthcare stakeholders representing 70 countries from all sectors of healthcare.

Released:
4-Jun-2018 8:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 695192

Best Podium and Poster Presentations Awarded at ISPOR 2018

ISPOR—The Professional Society for Health Economics and Outcomes Research

ISPOR, the professional society for health economics and outcomes research, announced the Best Podium and Poster Research Presentation awardees for its ISPOR 2018 conference held in Baltimore, MD, USA on May 19-23, 2018.

Released:
29-May-2018 10:40 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    23-May-2018 3:10 PM EDT

Article ID: 694462

Artificial Intelligence: Is It the “Next Big Thing” in Healthcare?

ISPOR—The Professional Society for Health Economics and Outcomes Research

ISPOR, the professional society for health economics and outcomes research, held a session, “Is Artificial Intelligence the Next Big Thing in Healthcare Decision Making?”, at ISPOR 2018 in Baltimore, MD, USA.

Released:
14-May-2018 7:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Plenary3_ISPOR_KyleKlein_KKP11780.jpg
  • Embargo expired:
    23-May-2018 2:20 PM EDT

Article ID: 694461

Strengths and Limitations of Patient Preferences to Inform Regulatory Decisions

ISPOR—The Professional Society for Health Economics and Outcomes Research

ISPOR, the professional society for health economics and outcomes research, held its third plenary session, “Examining the Role of Patient Preferences to Inform Regulatory Decisions,” this morning at ISPOR 2018 in Baltimore, MD, USA.

Released:
14-May-2018 7:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    23-May-2018 10:05 AM EDT

Article ID: 694458

How Much Is the United States Actually Spending on Prescription Drugs?

ISPOR—The Professional Society for Health Economics and Outcomes Research

ISPOR, the professional society for health economics and outcomes research, held a session, “When Research Questions Collide: How Much Is the United States Actually Spending on Drugs?”, at ISPOR 2018 in Baltimore, MD, USA.

Released:
14-May-2018 7:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    22-May-2018 7:00 PM EDT

Article ID: 694452

Addressing Challenges of Value Assessment in Healthcare

ISPOR—The Professional Society for Health Economics and Outcomes Research

ISPOR, the professional society for health economics and outcomes research, held a session, “How Can We Address the Current Challenges in Value Assessment?”, at ISPOR 2018 in Baltimore, MD, USA.

Released:
14-May-2018 7:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    22-May-2018 4:25 PM EDT

Article ID: 694450

ISPOR Panel Discusses Recommendations and Rationale of “Making Medicines Affordable: A National Imperative”

ISPOR—The Professional Society for Health Economics and Outcomes Research

ISPOR, the professional society for health economics and outcomes research, held a session, “‘Making Medicines Affordable: A National Imperative’—Reflections on the National Academies Report” [IP11], ISPOR 2018 in Baltimore, MD, USA.

Released:
14-May-2018 7:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Showing results

110 of 191





Chat now!